Related Experiment Video
Updated: Apr 28, 2026

A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
Sleep-disordered breathing and cardiovascular disease
1Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Kentucky, College of Medicine, Lexington, KY 40536-00847, USA. bphil95@aol.com
Insights
Untreated sleep apnea is a significant risk factor for hypertension. CPAP treatment can lower blood pressure, yet sleep apnea is often overlooked in hypertension management strategies.
Area of Science:
- Cardiology
- Sleep Medicine
- Hypertension Research
Background:
- Untreated sleep apnea is a recognized risk factor for hypertension.
- Cardiovascular conditions are strongly associated with sleep-disordered breathing (SDB).
- Current hypertension management guidelines often fail to mention SDB screening or treatment.
Purpose of the Study:
- To highlight the link between sleep apnea and cardiovascular diseases.
- To emphasize the importance of SDB in hypertension management.
- To review the cardiovascular sequelae of SDB and the impact of CPAP treatment.
Main Methods:
- Review of existing cross-sectional and prospective studies on SDB and cardiovascular conditions.
- Analysis of treatment studies involving CPAP therapy for SDB.
- Synthesis of evidence linking SDB to hypertension, heart failure, and arrhythmias.
Main Results:
- CPAP treatment effectively reduces blood pressure, comparable to pharmacological monotherapy.
- Strong associations exist between SDB and hypertension, congestive heart failure, and bradyarrhythmias.
- CPAP treatment shows potential for improving or reducing the risk of cardiovascular sequelae of SDB.
Conclusions:
- Sleep apnea is a critical, often overlooked, factor in hypertension and other cardiovascular diseases.
- Screening for and treating sleep apnea should be integrated into cardiovascular disease management.
- Further prospective studies are required to confirm SDB-cardiovascular disease relationships and risks.
Abstract:
Untreated sleep apnea is a risk factor for hypertension, and CPAP treatment effects a blood pressure reduction comparable to that of pharmacologic monotherapy. Nevertheless, many current papers addressing the rapid increase in prevalence of hypertension and purporting to outline its management do not mention looking for or treating sleep apnea as a strategy. In addition to hypertension, virtually every adverse cardiovascular condition has been strongly associated with sleep disordered breathing in cross-sectional studies. There are also small prospective studies of the relationship between sleep-disordered breathing (SDB) and coronary heart disease and atrial fibrillation. Further, treatment studies show improvement or reduced risk of most cardiovascular sequelae of SDB with CPAP treatment. Beyond hypertension, which is well established, the strongest relationships between SDB and cardiovascular disease appear to be with congestive heart failure and bradyarrhythmias. Prospective studies are needed to confirm these relationships and to further delineate the risk.
More Related Videos
Related Concept Videos
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Other Pulmonary Disorders
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Sleep Apnea
The condition is more prevalent among...

